FDA permits advertising of new remedy just device to lessen wheezing and mild sleep apnea Kumar Jeetendra | February 6, 2021 Now, the U.S. Food and Drug Administration approved marketing of a new prescription only device intended to reduce snoring and moderate obstructive sleep apnea. Unlike devices used while patients sleep, this is the first device used while awake that is intended to improve tongue muscle function, which in time helps prevent the tongue from collapsing …
